Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. NOW
3. TSLA
4. TXN
5. GOOG
6. IBM
7. LVS
8. INTC
9. RJF
10. KNX

Go back to Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 50.76 --0 (-0%)
Previous Close $50.76    52 Week High $45.58 
Open $50.76    52 Week Low $37.82 
Day High $50.76    P/E N/A 
Day Low $50.76    EPS $0.00 
Volume 3,592       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 50.76 --0 (-0%)
Previous Close $50.76    52 Week High $45.58 
Open $50.76    52 Week Low $37.82 
Day High $50.76    P/E N/A 
Day Low $50.76    EPS $0.00 
Volume 3,592       

SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.27 --0 (-0%)
Previous Close $1.27    52 Week High $3.85 
Open $1.27    52 Week Low $1.25 
Day High $1.27    P/E N/A 
Day Low $1.27    EPS $-0.28 
Volume 14,156